Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine ...
The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...
Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover ...
Scientists assumed that one specific immune cell subtype was required for mRNA vaccination to activate the immune system. But ...
The mantis shrimp prowls the shallow waters of the world’s oceans, armed with some of the most complex eyes in the animal ...
Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.
WashU Medicine researchers have described how mRNA cancer vaccines engage the immune system, through an unconventional pathway involving two subsets of immune cells called dendritic cells.
In an interview with Targeted Oncology, Naomi Haas, MD, discusses the evolving landscape of adjuvant and neoadjuvant immune ...
Delivering a Complete Clinical Digital Pathology Ecosystem Combining Aperio HALO AP DX Image Management System and ...
Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis in patients with colon and rectal cancer.
Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual ...
Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results